Nomura Securities Reiterates a 'Buy' on HSBC Holdings (HBC); Solid Results Support Positive Thesis
Tweet
Share
E-mailGet Alerts HBC Hot Sheet
Price: $55.69 +0.87%
Rating Summary:
7 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Nomura Securities maintains a 'Buy' on HSBC Holdings (NYSE: HBC), price target 725p.
Analyst, Robert Law, said, "We regard HSBC’s results as supportive of our investment case. Full-year results are broadly in line with our expectations. HSBC reported group PBT of USD 21.9bn, compared with our estimate of USD 22.4bn, similar to the consensus expectation. We see the results as a positive read-across for STAN. Although there is downgrade risk in the sector generally, we see less risk at HSBC and STAN and reiterate our rating on the back of these results."
For an analyst ratings summary and ratings history on HSBC Holdings click here. For more ratings news on HSBC Holdings click here.
Shares of HSBC Holdings closed at $45.60 yesterday.
Analyst, Robert Law, said, "We regard HSBC’s results as supportive of our investment case. Full-year results are broadly in line with our expectations. HSBC reported group PBT of USD 21.9bn, compared with our estimate of USD 22.4bn, similar to the consensus expectation. We see the results as a positive read-across for STAN. Although there is downgrade risk in the sector generally, we see less risk at HSBC and STAN and reiterate our rating on the back of these results."
For an analyst ratings summary and ratings history on HSBC Holdings click here. For more ratings news on HSBC Holdings click here.
Shares of HSBC Holdings closed at $45.60 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Nomura, HSBCSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
